SCHEMBL26655136

SCHEMBL26655136

COc1c(Br)ccc(NC2COC2)c1N

nearest known ligand 0.31

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.31
FEN1 P39748 1/20 0.31
MBOAT4 Q96T53 1/20 0.31
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30
KMT2A Q03164 1/20 0.30
PTGER4 P35408 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26654487 0.89 PDE1B (0.35)
SCHEMBL26654802 0.86 PTGER4 (0.35) ALOX5APFEN1MBOAT4MEN1USP2
SCHEMBL26654532 0.86 FYN (0.37) MAPTPTGER4
SCHEMBL26654649 0.78 MAPT (0.39) MAPTKMT2APTGER4
SCHEMBL26654848 0.74 ALOX5AP (0.36) ALOX5APFEN1MEN1USP2MAPT
SCHEMBL26655014 0.70 PTGER4 (0.36) ALOX5APFEN1MEN1USP2MAPT
SCHEMBL26654832 0.69 MAPT (0.41) MAPTPTGER4
SCHEMBL24344353 0.68 ALOX5AP (0.39) ALOX5APFEN1MEN1USP2MAPT
SCHEMBL22864666 0.67 POLB (0.44) MEN1MAPTKMT2A
SCHEMBL28627251 0.67 AAK1 (0.41) MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4524139-A1 IMIDAZOPYRIDAZINE SUBSTITUTED BENZENE RING DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE Shanghai Simr Biotechnology Co., Ltd. (CN) 2025-03-19 EP disclosed
CN-117069725-A Imidazopyridazine substituted benzene ring derivative, preparation method, pharmaceutical composition and application 上海赛默罗生物科技有限公司 2023-11-17 CN disclosed
WO-2023216753-A1 IMIDAZOPYRIDAZINE SUBSTITUTED BENZENE RING DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE 上海赛默罗生物科技有限公司 2023-11-16 WO disclosed